Xcopri (cenobamate) is a newer antiseizure medication that was approved by the FDA in 2019 for treating partial-onset seizures in adults. Based on the search results, there is no clear data on how well it works specifically for juvenile myoclonic epilepsy. However, it may be an option to discuss with your doctor if other Show Full Answer

Xcopri (cenobamate) is a newer antiseizure medication that was approved by the FDA in 2019 for treating partial-onset seizures in adults. Based on the search results, there is no clear data on how well it works specifically for juvenile myoclonic epilepsy. However, it may be an option to discuss with your doctor if other medications have not helped control your seizures. The most common side effects of cenobamate include sleepiness, dizziness, fatigue, headache, nausea, and double vision. More serious risks include allergic reactions, low blood cell counts, and thoughts of harming yourself. It's important to let your doctor know if you experience any concerning side effects.

 This AI-generated response comes from MyEpilepsyTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

Juvenile Myoclonic Epilepsy: Symptoms, Causes, and Treatment